Platform includes an expanded global library.
Thread Research revealed in a company press release that it has officially launched a suite of new complex electronic clinical outcome assessment (eCOA) features, including an expanded global library, to its decentralized research platform serving global researchers. Reportedly, the new features enable the platform to process complex eCOA data collection while presenting only relevant data to the site teams and participants.
Thread stated that with these new features, clients can now:
"The launch of these enhanced eCOA features provides our clients with the next-generation functionality needed to increase speed, scale consistently, and reduce study risks," said John Reites, co-founder, CEO, Thread, in the aforementioned release. "These features bring us closer to bringing research to everyone, everywhere with our innovative approach to Patient-First eCOA."
Reference: THREAD LAUNCHES SUITE OF NEW FEATURES AND EXPANDED LIBRARY TO MODERNIZE ECOA SOLUTIONS. PR Newswire. September 26, 2023. Accessed September 27, 2023. https://www.prnewswire.com/news-releases/thread-launches-suite-of-new-features-and-expanded-library-to-modernize-ecoa-solutions-301938170.html
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.